OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
J Venom Res
Open-access
Aptamers
Open-access
Aptamers 2019
03-04 April 2019, Oxford
Submit a manuscript

Blog Full Right Sidebar

With Frame
A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot, which was created for the bliss of souls like mine. I am so happy, my dear friend, so absorbed in the exquisite sense of mere tranquil existence, that I neglect...
Read More
We are delighted to announce that Dr Nebojsa Janjic will chair Aptamers 2020. Dr Nebojsa Janjic is the Chief Science Officer at SomaLogic. Prior to joining SomaLogic, Dr Janjic was the CSO at Replidyne, Inc, a biotechnology company focusing on the development of small-molecule antibacterial agents. Prior to Replidyne, he was Senior Director of Drug Discovery at NeXstar Pharmaceuticals. At NeXstar, he was responsible for creating...
Read More
The INSOAP’s Aptamers meeting has been running at Oxford since 2014, and has attracted attendance from several key scientists in the field, industry researchers, solution providers, and young and emerging researchers. We are now inviting proposals for chairing the 2020 meeting. If you are interested in chairing it, or would like to suggest a chair, please get in touch with by emailing AptamersOxford@gmail.com or Muhammad.sohail@st-hildas.ox.ac.uk....
Read More
Fee Structure Early bird and group discounts are available. Register 3 for the price of 2 until 31 December 2019 (cheapest registration free – Promocode: 3for2)* Register 4 for the price of 3 any time (cheapest registration free – Promocode: 4for3)* Fees apply to payments made on or before the indicated deadlines and not to the date of submission of the registration form. All prices in...
Read More
TAGCyx Biotechnologies Inc. is a drug discovery and development company based in Japan, spun out of Riken Research Institute. We utilizes its proprietary, artificial nucleotide base pair technology invented by Dr. Ichiro Hirao to generate unique DNA aptamer, Xenoligo®, for therapeutic purposes.  Amongst various type of aptamers, the advantage of Xenoligo® are: 1) comprised of DNA, 2) achieves high affinity and specificity to the target, 3)...
Read More
ATDBio was established to provide high quality oligonucleotides to scientists around the world. ATDBio oligonucleotides are used successfully in academic and commercial research in the fields of genetics, genomics, molecular biology, biochemistry, biotechnology and nanotechnology. We supply a wide range of custom-made unmodified and chemically modified oligonucleotides for small and large scale applications. ATDBio specialises in highly modified oligonucleotides. Each oligonucleotide we make is unique, and we...
Read More
1 2 3 37

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Recent News

Dr Nebojsa Janjic to Chair Aptamers 2020
July 21, 2019
Proposals to Chair Aptamers 2020 invited
May 20, 2019
Fee Structure 2020
May 20, 2019

Recent Cases